Glucotrack earnings were -$26.5M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest GCTK earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$6.8M, down 32.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GCTK reported annual earnings of -$22.6M, with 218.4% growth.
Glucotrack (NASDAQ: GCTK) reported Q1 2025 earnings per share (EPS) of -$0.67, up 94.29% year over year. Total GCTK earnings for the quarter were -$6.83 million. In the same quarter last year, Glucotrack's earnings per share (EPS) was -$11.73.
As of the last Glucotrack earnings report, Glucotrack is currently losing money. Glucotrack's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$26.50 million, a 203.31% increase year over year.
What was GCTK's earnings growth in the past year?
As of Glucotrack's earnings date in Q2 2025, Glucotrack's earnings has grown year over year. GCTK earnings in the past year totalled -$26.50 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.